Campbell & Co Investment Adviser’s Guardant Health GH Stock Holding History

Campbell & Co Investment Adviser’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.05M	Sell	6,979 -41,568	-86%	-$4.52M	0.05%	527
2026 Q1	$4.48M	Buy	48,547 +35,790	+281%	+$3.59M	0.26%	88
2025 Q4	$1.3M	Sell	12,757 -6,271	-33%	-$561K	0.06%	459
2025 Q3	$1.19M	Buy	+19,028	New	+$1.04M	0.09%	348
2025 Q1	–	Sell	-56,389	Closed	-$1.72M	–	1138
2024 Q4	$1.72M	Buy	+56,389	New	+$1.59M	0.13%	221
2023 Q4	–	Sell	-32,396	Closed	-$960K	–	1181
2023 Q3	$960K	Buy	+32,396	New	+$1.14M	0.11%	281

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Campbell & Co Investment Adviser's GH Position: Q2 2026 in Review

Campbell & Co Investment Adviser reduced its Guardant Health (GH) stake by 86% in Q2 2026, selling an estimated $4.52M and leaving 6,979 shares worth $1.05M. The position accounts for 0.05% of the portfolio, ranked #527.

Campbell & Co Investment Adviser first reported a position in GH in Q3 2023 and has held it in 6 quarters since. The position peaked at $4.48M in Q1 2026. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Campbell & Co Investment Adviser held 6,979 shares of Guardant Health worth $1.05M as of Q2 2026.
Campbell & Co Investment Adviser sold 41,568 Guardant Health shares in Q2 2026, an estimated $4.52M.
Guardant Health made up 0.05% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #527 holding.
Campbell & Co Investment Adviser first reported a position in Guardant Health in Q3 2023 and has held it in 6 quarters since.
Campbell & Co Investment Adviser's Guardant Health position peaked at $4.48M in Q1 2026.
600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.